AAPS will be the exclusive authority advising RX on scientific focus areas that affect the approximate 8,000-person event beginning in spring 2023 under a new agreement. AAPS will play a key role in reviewing and selecting programming for Interphex, particularly in areas focused on the intersection of business and science.
AAPS, a non-profit, professional society of 7,000 pharmaceutical scientists, is focused on raising the bar for science across the pharmaceutical industry. Through this new agreement, the organization will share its expertise with Interphex, an event that brings together business leaders and scientists from across the commercial contracting space.
“This is an important step for us in pursuing our mission of bringing scientists together to advance cures and therapies that will help patients around the world,” AAPS President Patrick Sinko, Ph.D., said. “We are going to support RX in creating a scientific experience at Interphex that helps industry professionals look into the future while solving today’s problems.”
“The collaboration with AAPS is an important next chapter for Interphex,” Marie Brown, Group Vice President at RX, said. “Interphex has traditionally been an event primarily focused on product discovery and finding solutions to effectively develop and manufacture quality products. We are excited that AAPS will elevate and expand the content to attract and satisfy the educational needs of research scientists and provide that important link between science and commercialization.”
AAPS and RX are now developing plans for the 2023 Interphex meeting, taking place April 25-27, 2023, at the Javits Center in New York City. The organizations look forward to announcing plans that will benefit the attendees and industrial partners participating in both organizations’ events, including AAPS’ National Biotechnology Conference (NBC), taking place April 23-26, 2023, in Philadelphia, PA.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!